Autolus Therapeutics (AUTL)
(Delayed Data from NSDQ)
$4.00 USD
-0.08 (-1.96%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.00 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/14/24 |
---|---|
Current Quarter | -0.10 |
EPS Last Quarter | -0.44 |
Last EPS Surprise | -69.23% |
ABR | 1.38 |
Earnings ESP
|
-53.92% |
---|---|
Current Year | -0.71 |
Next Year | -0.57 |
EPS (TTM) | -1.19 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 50.00M | NA | 27.66M | 69.44M |
# of Estimates | 2 | NA | 4 | 4 |
High Estimate | 50.00M | NA | 57.23M | 109.50M |
Low Estimate | 50.00M | NA | 0.14M | 39.23M |
Year ago Sales | 1.29M | 0.00M | 1.70M | 27.66M |
Year over Year Growth Est. | 3,775.97% | NA | 1,529.22% | 151.02% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.10 | -0.21 | -0.71 | -0.57 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.28 | -0.30 | -1.23 | -0.95 |
High Estimate | 0.02 | -0.18 | -0.54 | -0.37 |
Low Estimate | -0.28 | -0.30 | -1.23 | -0.95 |
Year ago EPS | -0.23 | -0.26 | -1.20 | -0.71 |
Year over Year Growth Est. | 56.52% | 19.23% | 40.83% | 19.33% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.10 | -0.21 | -0.71 | -0.57 |
7 Days Ago | -0.10 | -0.21 | -0.71 | -0.57 |
30 Days Ago | -0.09 | -0.22 | -0.73 | -0.49 |
60 Days Ago | -0.22 | -0.18 | -0.85 | -0.53 |
90 Days Ago | -0.23 | -0.24 | -0.89 | -0.57 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.16 | -0.18 | -0.54 | -0.37 |
Zacks Consensus Estimate | -0.10 | -0.21 | -0.71 | -0.57 |
Earnings ESP | -53.92% | 15.09% | 24.12% | 35.59% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.44 | -0.26 | -0.26 | -0.23 | NA |
Estimate | -0.26 | -0.24 | -0.22 | -0.28 | NA |
Difference | -0.18 | -0.02 | -0.04 | 0.05 | -0.05 |
Surprise | -69.23% | -8.33% | -18.18% | 17.86% | -19.47% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more